PDCD1 and type 1 diabetes mellitus: (2) Islet β cell damage: inhibition of the PD-1/PD-L1 pathway leads to the activation of autoimmune T cells, increasing their infiltration and destruction of islet β cells [17], which may lead to insulin deficiency and ICI-T1DM.